Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatrice Detti

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Cancer Investigation|September 27, 2014
Docetaxel in castration-resistant prostate cancer: a single-centre experienceBeatrice Detti, Detti Beatrice, Davide Franceschini, et al.
World Journal of Urology|March 13, 2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter studyLuca Triggiani, Rosario Mazzola, Stefano Maria Magrini, et al.
International Journal of Radiation Biology|March 4, 2025
Significant interruptions in radiotherapy during curative treatment for prostate cancer are correlated with poorer oncological outcomesMiriam Tomaciello, Antonio Sciurti, Luisa Caprara, et al.
European Urology Oncology|February 7, 2025
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter SeriesLudwige Abancourt, Muhammad Ali, Magali Quivrin, et al.
European Urology Oncology|April 14, 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective StudyNicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, et al.
Prostate Cancer and Prostatic Diseases|March 18, 2025
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE studyGianluca Ingrosso, Eleonora Festa, Saverio Caini, et al.
La Radiologia Medica|February 18, 2024
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE)Gianluca Ingrosso, Elisabetta Ponti, Giulio Francolini, et al.
European Urology|July 24, 2019
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal RadiotherapyElise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 21, 2024
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)Matteo Bauckneht, Francesco Lanfranchi, Domenico Albano, et al.
Radiology. Imaging Cancer|May 16, 2025
Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT StudyFrancesco Lanfranchi, Liliana Belgioia, Domenico Albano, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Cancer Investigation|September 27, 2014
Docetaxel in castration-resistant prostate cancer: a single-centre experienceBeatrice Detti, Detti Beatrice, Davide Franceschini, et al.
World Journal of Urology|March 13, 2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter studyLuca Triggiani, Rosario Mazzola, Stefano Maria Magrini, et al.
International Journal of Radiation Biology|March 4, 2025
Significant interruptions in radiotherapy during curative treatment for prostate cancer are correlated with poorer oncological outcomesMiriam Tomaciello, Antonio Sciurti, Luisa Caprara, et al.
European Urology Oncology|February 7, 2025
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter SeriesLudwige Abancourt, Muhammad Ali, Magali Quivrin, et al.
European Urology Oncology|April 14, 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective StudyNicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, et al.
Prostate Cancer and Prostatic Diseases|March 18, 2025
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE studyGianluca Ingrosso, Eleonora Festa, Saverio Caini, et al.
La Radiologia Medica|February 18, 2024
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE)Gianluca Ingrosso, Elisabetta Ponti, Giulio Francolini, et al.
European Urology|July 24, 2019
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal RadiotherapyElise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 21, 2024
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)Matteo Bauckneht, Francesco Lanfranchi, Domenico Albano, et al.
Radiology. Imaging Cancer|May 16, 2025
Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT StudyFrancesco Lanfranchi, Liliana Belgioia, Domenico Albano, et al.
Pageof 12